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Discussion After the Speeches of Dr. Krogh and Dr. Fleck
QUESTION, Professor King: How transferable is the 3M magic to
other companies? For example, is it unique to the particular industries
that 3M is in? Is it due to the history of the company? Is it something
that can be duplicated in any other spot?
ANSWER, Dr. Krogh: A lot of people ask us how we do it. I do not
know of any way to do it easily, unless you change the culture of the
company completely. It is not an easy thing to do. It is something we
have to fight to maintain at all times because we have forces within our
own company which tend to tear it down.
I mentioned the nay-sayers. One of the things that can happen in
any company is that the nay-sayers will win or you will threaten the
culture of the company by going into a business that some of them do not
want you to go into. It is very difficult.
On the other hand, we have been quite successful in transferring this
magic to our foreign subsidiaries outside the United States, probably be-
cause we have sent our people over to start those subsidiaries and we
continue the flow of people both ways. If another company wanted to
change its culture, it would have to exchange people with a company like
3M. I think that would be the only successful way in which it could
occur. We don't propose to do that.
QUESTION, Professor King: Dr. Fleck, as I listened to your story I
wondered if it presupposes a very close relationship between you and
your customers as a basis for what you are trying to do in the way of
innovation. Suppose there are others who want to do the same thing that
you are doing, what about the competitive factors? Does that throw a
monkey wrench in the works? You have a very good theory there, with
which I basically agree.
ANSWER, Dr. Fleck: If you concentrate on the process technology,
you are more likely to keep that within your company than a product
technology. That is not the reason we are doing it, but if you have an
unpatented product technology, it is very difficult to hang onto it. If it is
processes that you do within your own plant, you are able to keep control
of those and not necessarily share them with your customer as you would
a product development.
One of the differences is that in many cases 3M would be selling a
product to a consumer. We are selling a product to an assembler, but
they have specified the product in advance, generally speaking, and they
have control over the design. We found that when we started trying to
design a product, we ended up spending a fair bit of money and not really
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getting any return for it. Whereas, if we can stay "mean and lean" with a
higher emphasis on the variable side of the cost structure, we remain
competitive.
We are working hard at process development, including quality,
which is one of the real drivers in manufacturing these days. We think it
enables us to keep better in tune with what it is our market is looking for
at the present time.
QUESTION, Professor King: That presupposes, I assume, that the
customer does not take the product in-house using your technology. I
assume that you have to have some protection over the technology, or is
it just straight know-how?
ANSWER, Dr. Fleck: No, it is more in the processes of how to do
things better and more cheaply while increasing quality. It is not some-
thing that the customer really gets to see. It is just that we come up with
a higher quality product that we are able to produce more efficiently.
Our focus is on maximizing our limited resources. We cannot go
twelve or thirteen years without making a profit or we will not be
around. You have to have the financial strength to be able to wait fifteen
years for a product to come down the line. In a very competitive busi-
ness like ours, you cannot let things get out of control or you will go
down the tubes quickly.
QUESTION, Professor King: Dr. Krogh, you said that everybody
has the right to spend 15% of his or her time on the creation of new
products, is that right? How do you control that? Is that limited to a
certain category of people? It sounds like a nice combination, but the
15% has got to produce something. Is it just that if you get a success
story, it balances the failures in some other cases?
ANSWER, Dr. Krogh: At any given time less than 5% of the people
are using the 15% plan. We wish there were more people with ideas to
work on so we would have more things to choose from. Some people do
abuse it, but if they have a good idea and they are working on it, we just
sort of look the other way. Remember that 15% of the work week in
addition to Saturdays, Sundays and evenings amounts to an awful lot of
time if you really get into something that interests you. It has never been
a problem. If we ask them to do something, they will set their idea aside
and get that high priority task done ahead of time. It has never been an
issue. The only issue is that not enough people use it.
QUESTION, Professor Edwards: I want to ask Dr. Fleck a ques-
tion. What do you do to protect yourself from becoming obsolete? In
other words, if there is a change that would make your improvements on
the process irrelevant because the product is no longer going to be pro-
vided, what do you do?
ANSWER, Dr. Fleck: We certainly have to keep abreast of what is
going on. The difference is that we are not necessarily developing it our-
selves. We keep in touch with our customers to find out if anything is
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being developed. We attend fairs and exhibitions and read what is avail-
able. We certainly want to watch what is happening, but we do not put a
lot of resources into trying to develop our own final product.
My father used to be in the toy business many years ago. He had an
R&D department - he went to the toy show in New York each year and
looked at what was going on; then either copied it or licensed it.
You have to determine whether, in your specific business and in
your specific niche, it makes sense to invest in R&D. You must look at
whether it makes sense in your particular situation.
QUESTION, Professor King: How long a life cycle do you average
on new products, Dr. Krogh? You have to keep up this tremendous mo-
mentum. So far it has worked well, but you also have a limitation in
terms of product life cycles. You have invested a lot of money in product
development and you need to get that back. Do you have to meet any
standards on the length of the product life cycle?
ANSWER, Dr. Krogh: Life cycles are very interesting. They are
very diverse. One product which has probably not changed significantly
for thirty years is the roofing granules used on asphalt shingles. The only
thing we have done is to increase the color selection, and make the white
a little whiter. Basically that product life cycle is extremely long.
We have other products with very short life cycles, maybe six
months to a year. We have gotten ourselves into a leapfrog situation
with our competitors because we have not invested in the basic research,
the technology-building required to produce a long product life cycle.
We frequently have to go back and put more money into the technology-
building in order to get a product that is so far advanced that it has a
longer product life cycle.
If you do not pay attention to the technology-building, product life
cycles in a tight competitive race can become so incredibly short that it is
no longer productive. We have to take the bull by the horns and say,
"We are not going to get into that race. We are going to do what is
necessary to stay competitive or maintain market share while building
the next generation of products."
Let me give you a few examples. Number thirty-three electrical
tape, the stretchy black vinyl tape, first came out in 1950. It has not
changed very much. Packaging tape, on the other hand, has gone
through an enormous evolution in the last ten years. Prior to that it was
a very stable product and did not change very much. In the clear tapes,
the kind you have on your desk top, there really have been only two
products in the entire life time, cellophane tape and now cellulose acetate
tape. There have been improvements, but the product and the form of
the product have had very long life cycles. Yet masking tape, particu-
larly for use in masking automobiles continually demands a little bit bet-
ter feel, a little more conformability. In addition, whenever the
automobile manufacturers change the paint on an automobile, which
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they do about every two or three years, we have to change the tape. So
sometimes other products life cycle affects our own product. So in tapes,
I would say the average life cycle is five to ten years.
QUESTION, Professor King: The 3M setup depends on creative in-
dividuals. Do you consider that in your hiring decisions, or is it just a
potluck? How do you select your people?
ANSWER, Dr. Krogh: That is a fascinating question. Early in the
history of the company, we used to hire farm boys who had gone through
the local universities. Farmers are independent people, the kind that
make good researchers because they will not take no for an answer.
We look at grades and participation in activities, things you would
probably do in hiring anyone. But I think there is a self-selection pro-
cess. When we describe 3M to certain individuals, some people, even
though they look very good on paper and interview well, will turn us
down because they would be very uncomfortable with our style of
management.
So it is a complex process. More than anything else we try to teach
people to be creative. Many people become creative simply because it is
expected. For others, the creativity demonstrated by co-workers chal-
lenges them. In addition, rewards for creativity provide incentives.
Some people just never make it, but there are a lot of jobs in our
laboratories and our company which are very routine. We need to have
those jobs done, and often these people are very good at those jobs.
Quality control testing and some kinds of process development are very
routine jobs which require specialized skills. The interface between our
laboratory people and our patent counsel is handled by patent liaisons
who must have specialized knowledge. So there are very useful ways of
utilizing those people who are not as creative.
QUESTION, Dr. Strub: The 3M spirit seems to be mainly applica-
ble in research and product development and not in manufacturing or
other areas. I find it hard to believe that this is the only U.S. company
with such a style of management. Do you know of any U.S. companies
which have broader applications of similar systems?
ANSWER, Dr. Krogh: The entrepreneurial spirit spills over into
manufacturing and marketing because the general manager of a division
has a 25% new products target. The laboratory alone cannot meet that
target so there has to be a little bit of that entrepreneurial spirit in the
manufacturing and marketing side. It is a company culture, although it
really begins in R&D.
We are not the only company that does a good job. Hewlett-
Packard and Millikin also do a good job. Roger Millikin deliberately
studied the 3M company and its management style and copied it. Merck
is a good illustration in a somewhat narrower field, but very innovative
nevertheless. I think the interesting parallel between Merck and 3M is
the freedom they give their people in the laboratory.
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QUESTION, Mr. Blackburn: We heard earlier today about the Jap-
anese corporate business culture. Does 3M or Dow have manufacturing
operations in Japan?
We have been looking at the transplant problems the other way,
Japanese manufacturing culture being imported to North America. How
does the corporate culture transplant? Do the sorts of things you are
talking about transfer the other way?
ANSWER, Dr. Krogh: We have a Japanese afiliate. Fifty percent
of the Japanese company is run and staffed by 3M, using our technology.
It is a very successful company. There has been no trouble in transfer-
ring the technology there. When we build a new plant to make a product
in Japan, it makes a good product from day one, that is better than we
do.
The Japanese are also becoming very innovative. We have been
building up our laboratory there for a number of years, seriously in the
last six to eight years. They are becoming extremely innovative and very
fast in product development. They are also good inventors. I think we
have transferred a lot of the culture.
Now, interestingly enough, other people have compared the Japa-
nese management style and the 3M management style and say they are
quite alike. It is consensus building, but the Japanese take it a little fur-
ther than we do.
QUESTION, Mr. Conway: This afternoon we heard the horrors of
product liability. In your R&D and product selection, what impact does
product liability have on the decision-making process?
ANSWER, Dr. Krogh: We have deliberately taken some product
lines off the market because the potential liability was too high. We have
just established a corporate committee on risk and liability. Our CEO is
extremely sensitive to the subject. We had one product recall last year,
and it was quite expensive.
Product liability is an area in which our laboratory people, espe-
cially, have to be extremely sensitive. It has to be supported by staff
groups who know what types of liability problems may arise, for exam-
ple, environmental problems such as emissions and disposal. We are
very sensitive to product liability.
QUESTION, Mr. Reifsnyder: When you initiated this dual career
ladder was it intended for people coming out of businesses and colleges?
ANSWER, Dr. Krogh: We started the dual ladder in 1956 when we
appointed our first research associate, now called the corporate scientist.
Because we wanted to make it extremely pure, we took a good technical
manager and decided he was the best candidate to be our first research
associate. He had been managing fourteen or fifteen people. We left him
with a couple of technicians, but over a period of about a year all those
were taken away. He was all by himself in the laboratory because he was
on that non-management side of the ladder. After about two years he
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came back to management and said, "Please make me a manager again
so I can have somebody to help me."
We have learned not to use it as a dumping ground. In other words,
if you have a field manager, do not put him on the technical side of the
ladder to get him out of management. As a matter of fact we just re-
cently went through this again, and the Technical Forum, which has a
senate and a governing board, put together an ad hoc committee just to
re-examine the problem of whether we should place a director or a labo-
ratory manager on the technical side of the ladder, and if so, how we
should go about it. I recommended that we leave him the same title or
something similar. Do not make him a corporate scientist, for example,
if he is a director. Give him a year to prove he can do it, and if he can,
make him a corporate scientist. If he cannot, put him where he belongs
in the ladder. One of the key things is that we have been very careful not
to dump. It has been used as a dumping ground by other companies and
they have abandoned the system. At the lower levels there is quite a bit
of transfer back and forth. After all, a young research specialist who has
never had a chance to be a supervisor will want to try it. If he does not
like it, he may go back to the other side, and that is not a problem. It is
only when you get to the two top rungs that it becomes a problem.
You also have to be sure that you do not have a quota on the techni-
cal side of the dual ladder. There is a limit on the number of managers
and directors you need. The argument has frequently been made by peo-
ple who aspired to the technical side that they have to wait in line until
there are openings. That is not so. They can earn a position at any stage
of their career if they have proven they can perform at that level. On the
other hand, if you are an aspiring technical director, you may have to
wait until somebody retires or moves on before you can get a manage-
ment job.
So there are pros and cons which must be communicated to both
sides. They are terribly suspicious that you are doing one thing for one
side and not to the other. But keeping it pure is really the key.
We have about thirty corporate scientists, and we meet with them
periodically as a technology planning and policy committee. The one
thing they emphasize to us again and again is that they are all different
and need to be treated differently. We have a few corporate scientists
who manage fourteen to fifteen people. Some do not want to manage
anybody and will not even take a technician because they just don't want
to be bothered. You have to be very adaptable when dealing with them.
QUESTION, Mr. Allen: No matter how freewheeling the environ-
ment may be, at some point the corporation must establish priorities and
may have to cancel projects, sometimes in their embryonic stages, some-
times when they are almost ready for commercialization.
There will be certain people who have worked perhaps a long-time
in those projects, have a tremendous commitment or are emotionally in-
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volved with those projects who will be disappointed by such a decision. I
assume, based on my own experience, that some of those people have
seen the success of others who have taken ideas into a small enterprise
venture capital operation and fared very well.
How do you address this situation in 3M? Do you encourage them
to go off and do these things? Do you discourage them? What is your
approach?
ANSWER, Dr. Krogh: Well, we have only two or three instances
where something from 3M has been taken outside with the company's
permission. We have essentially licensed the patents to the people. We
have one that may be a success and we have another one that I think is
going to be a success. Those are the only two I have heard of since I have
been with the company. The difference between 3M and a lot of compa-
nies is that our technologies are so interwoven that it is very difficult to
carve out a single piece and take it outside. Frequently, by the time the
management has convinced the people on the project that it is not worth
the effort, there is nothing left. The major mistake that most corpora-
tions make is to think they can succeed at everything simply because they
succeeded at a few things. It can be a management failure to try to pur-
sue things for too long. When that sort of project gets killed, even if it is
possible to move it outside, the venture capitalists refuse to put any
money into it and it dies automatically.
QUESTION, Professor King: Is the 3M approach useable in a small
company such as Fleck Manufacturing, or are you locked into servicing
existing markets and thus unable to be as freewheeling as at 3M? Is it a
matter of economics?
ANSWER, Dr. Fleck: I think in time we can spread our wings. In
terms of management style, many of the ways in which we. operate inter-
nally are probably very similar. Ours is quite an informal management
style; we try to seed it with bright new people each year, and we try to
delegate responsibility. Many aspects that Dr. Krogh has mentioned
here are features that we might have in our company. The difference is
that we certainly are not in the laboratory in the same sense, and we are
not developing products to be sold to the consumer.
One of our strategic objectives is to do what we are doing well
enough to generate resources that we will use - we call it the "wedge."
We are looking for something which will enable us to move off in another
direction profitably. But first we are very conscious of making sure we
do a good job on what we are doing now. We have grown quite rapidly
in the United States. We see a tremendous opportunity for a very sub-
stantial increase in just doing well what we are doing now.
COMMENT, Professor King: The spirit of innovation must exist if
we are going to succeed. During my visits at 3M I experienced it, and I
am sure I would experience it at Fleck Manufacturing Company.
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Thank you both for enlightening us on a very timely subject, partic-
ularly in light of the Free Trade Agreement.
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